What Defines Modern Cancer Treatment?

Why Modern Oncology Distinguishes Between Tumor-Directed Treatment, Supportive Medicine, and Integrative Approaches

Today, a cancer diagnosis often involves more complex treatment decisions than it did only a few years ago. Depending on the type of cancer and the individual clinical situation, treatment may include not only chemotherapy and radiotherapy, but also molecular diagnostics, immunotherapies, targeted medicines, as well as supportive and integrative measures.

This can easily lead to misunderstandings: Which treatments act directly against the tumor? Which approaches are intended to alleviate symptoms and side effects? And which measures support the patient without constituting cancer treatment in the strict sense?

Modern oncology clearly distinguishes between these different objectives. Each intervention serves a defined purpose — and not every option is suitable for every patient.

Tumor Treatment Begins with a Precise Diagnosis

The key question is not simply which therapies are generally available, but which treatment can reasonably be expected to provide clinical benefit in the individual case.

The first step is therefore to characterize the tumor as precisely as possible. In addition to the histopathological examination of tissue, this may include molecular tumor profiling, biomarker analysis, and next-generation sequencing (NGS).

NGS enables the simultaneous analysis of numerous selected regions of the tumor genome. Depending on the type of cancer and the clinical question, a liquid biopsy may also be considered. This involves analyzing tumor-derived material circulating in the blood, particularly cell-free tumor DNA.

For various advanced cancers, international guidelines recommend molecular testing when it may identify therapeutically relevant biomarkers. The method and scope of testing depend on the tumor type, stage of disease, and specific clinical question.

The European Society for Medical Oncology (ESMO) publishes recommendations on the use of multigene sequencing. Its complementary ESCAT classification helps assess molecular alterations according to the available level of clinical evidence. The American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network (NCCN) also include molecular testing within their tumor-specific and situation-specific guidelines.

Precision oncology does not replace guideline-based treatment. It complements established standards by adding biological information that may support more individualized and scientifically informed treatment decisions.

Learn more here about the diagnostic capabilities of the Hallwang Clinic and the process of molecular tumor analysis.

Antitumor Therapies Act Directly Against the Cancer

Tumor-directed treatment includes approaches intended to attack cancer cells, inhibit their growth, or limit their spread.

• Established treatment modalities: chemotherapy and radiotherapy
  
• Modern systemic therapies: immunotherapies, targeted therapies, and antibody-drug conjugates (ADCs), which are designed to deliver active substances directly into tumor cells
  
• Specific treatment approaches: antihormonal therapies as well as local ablative or interventional procedures, including stereotactic radiotherapy and, in selected indications, high-intensity focused ultrasound

The most appropriate option depends on the tumor type, stage of disease, molecular profile, previous treatments, and the patient’s overall condition. Decisions should always be based on clinical evidence, international guidelines — such as the ESMO Clinical Practice Guidelines — and an individualized assessment of potential benefits and risks.

An overview of modern cancer treatments available at the Hallwang Clinic can be found here.

Modern Oncology Treats More Than the Tumor

Cancer and its treatment may cause pain, fatigue, weight loss, infections, or emotional distress. Supportive medicine does not act directly against the tumor. Instead, it focuses on preventing and treating these symptoms and complications. It is an established component of quality-assured cancer care.

Supportive measures may include:

• pain management and the treatment of nausea or fatigue
• infection prevention and nutritional medicine
• physiotherapy and psycho-oncological support

These interventions may help alleviate symptoms, support quality of life, and enable planned antitumor treatments to be carried out as intended.

Integrative Medicine Complements Cancer Treatment

Integrative oncology does not replace established tumor-directed treatment. It complements evidence-based cancer care with selected measures that may help relieve symptoms, support physical functioning, or reduce emotional stress.

Professional organizations such as the Society for Integrative Oncology (SIO) and ASCO publish joint guidelines on selected interventions, including exercise programs, acupuncture for specific symptoms, and mind-body approaches such as yoga or meditation. The decisive factor is always the scientific evaluation of the specific therapeutic objective.

Integrative medicine is therefore neither alternative medicine nor a substitute for antitumor therapy. Depending on the individual situation, it may provide a meaningful complement to established cancer treatment.

Learn more here about the integrative treatment options available at the Hallwang Clinic and their role within an evidence-based therapeutic concept.

Each Measure Serves a Different Purpose

A clear distinction helps prevent supportive approaches from being confused with tumor-directed therapies and reduces the risk of misunderstanding treatment claims.

• To control or destroy the tumor:
  Immunotherapy, targeted therapy, chemotherapy, and radiotherapy
• To select treatment more precisely:
  Molecular diagnostics, biomarker analysis, and tumor profiling
• To reduce side effects:
  Supportive therapy, nutritional medicine, and pain management
• To support resilience and quality of life:
  Physiotherapy, psycho-oncological care, and selected integrative measures

What Must Be Considered in Every Individual Treatment Decision:

Not every diagnostic or therapeutic option is appropriate for every patient. Tumor biology, pre-existing conditions, previous treatments, and the patient’s general health all influence which approaches may be medically appropriate and justifiable.

Every treatment may involve risks and side effects. Whether a specific therapy is suitable can therefore only be determined after a complete review of the available medical findings and an individual medical assessment.

The Hallwang Clinic Follows an Integrated Treatment Concept

At the Hallwang Clinic, the distinction between diagnostic, antitumor, supportive, and integrative measures also forms the basis of treatment planning.

The first step is to review the patient’s existing medical records and findings. Depending on the tumor type, course of disease, and clinical question, further investigations such as molecular tumor analysis or liquid biopsy may be considered.

Based on this information, the medical team works together with the patient to develop an individualized treatment concept in which the purpose and function of each planned measure are clearly defined.

Before treatment begins, patients receive an overview of the proposed diagnostic and therapeutic steps, together with the anticipated costs.

Would You Like to Better Understand Your Treatment Options?

Many patients first wish to understand which diagnostic and therapeutic options may generally be considered in their situation.

An initial consultation provides an opportunity to review the available medical findings and discuss the possible next steps — before any decision regarding specific treatment is made.